BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 15274334)

  • 1. Changed adhesion molecule profile of Ewing tumor cell lines and xenografts under the influence of ionizing radiation.
    Könemann S; Malath J; Bölling T; Kolkmeyer A; Janke K; Riesenbeck D; Hesselmann S; Nguyen TP; Diallo R; Vormoor J; Willich N; Schuck A
    Anticancer Res; 2004; 24(3a):1637-44. PubMed ID: 15274334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of radiation induced apoptosis in Ewing Tumor cell lines characterized on a single cell level.
    Könemann S; Bölling T; Kolkmeyer A; Riesenbeck D; Hesselmann S; Vormoor J; Willich N; Schuck A
    Apoptosis; 2005 Jan; 10(1):177-84. PubMed ID: 15711933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of radiation on Ewing tumour subpopulations characterized on a single-cell level: intracellular cytokine, immunophenotypic, DNA and apoptotic profile.
    Könemann S; Bölling T; Schuck A; Malath J; Kolkmeyer A; Horn K; Riesenbeck D; Hesselmann S; Diallo R; Vormoor J; Willich NA
    Int J Radiat Biol; 2003 Mar; 79(3):181-92. PubMed ID: 12745883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time- and dose-dependent changes of intracellular cytokine and cytokine receptor profile of Ewing tumour subpopulations under the influence of ionizing radiation.
    Könemann S; Bölling T; Malath J; Kolkmeyer A; Janke K; Riesenbeck D; Hesselmann S; Diallo R; Vormoor J; Willich N; Schuck A
    Int J Radiat Biol; 2003 Nov; 79(11):897-909. PubMed ID: 14698958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced changes of telomerase activity in a human Ewing xenograft tumor.
    Schuck A; Poremba C; Lanvers C; Könemann S; Schleifer T; Wai D; Horn K; Hesselmann S; Braun Y; Frodermann B; Schäfer KL; Diallo RI; Rübe CE; Rübe C; Dockhorn-Dworniczak B; Willich N
    Strahlenther Onkol; 2002 Dec; 178(12):701-8. PubMed ID: 12491058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong inhibition of Ewing tumor xenograft growth by combination of human interferon-alpha or interferon-beta with ifosfamide.
    Sancéau J; Poupon MF; Delattre O; Sastre-Garau X; Wietzerbin J
    Oncogene; 2002 Oct; 21(50):7700-9. PubMed ID: 12400012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of angiogenic factors in Ewing tumor xenografts by the combination of human interferon-alpha or interferon-beta with ifosfamide.
    Sancéau J; Wietzerbin J
    Ann N Y Acad Sci; 2004 Dec; 1030():170-8. PubMed ID: 15659795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation-induced apoptosis of Ewing's sarcoma cells: DNA fragmentation and proteolysis of poly(ADP-ribose) polymerase.
    Soldatenkov VA; Prasad S; Notario V; Dritschilo A
    Cancer Res; 1995 Oct; 55(19):4240-2. PubMed ID: 7671228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LFA-1 and VLA-4 involved in human high proliferative potential-endothelial progenitor cells homing to ischemic tissue.
    Duan H; Cheng L; Sun X; Wu Y; Hu L; Wang J; Zhao H; Lu G
    Thromb Haemost; 2006 Dec; 96(6):807-15. PubMed ID: 17139377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib mesylate (STI571) interference with growth of neuroectodermal tumour cell lines does not critically involve c-Kit inhibition.
    Te Kronnie G; Timeus F; Rinaldi A; Crescenzio N; Spinelli M; Rosolen A; Ricotti E; Basso G
    Int J Mol Med; 2004 Sep; 14(3):373-82. PubMed ID: 15289888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin modulates telomerase activity in Ewing's sarcoma in vitro and in vivo.
    Lanvers-Kaminsky C; Winter B; Koling S; Frodermann B; Braun Y; Schaefer KL; Diallo R; Koenemann S; Wai D; Willich N; Poremba C; Schuck A
    Oncol Rep; 2005 Sep; 14(3):751-8. PubMed ID: 16077987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.
    de Hooge AS; Berghuis D; Santos SJ; Mooiman E; Romeo S; Kummer JA; Egeler RM; van Tol MJ; Melief CJ; Hogendoorn PC; Lankester AC
    Clin Cancer Res; 2007 Jan; 13(1):206-14. PubMed ID: 17200356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroectoderm-associated antigens on Ewing's sarcoma cell lines.
    Lipinski M; Braham K; Philip I; Wiels J; Philip T; Goridis C; Lenoir GM; Tursz T
    Cancer Res; 1987 Jan; 47(1):183-7. PubMed ID: 3024814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EWS/FLI1 regulates tumor angiogenesis in Ewing's sarcoma via suppression of thrombospondins.
    Potikyan G; Savene RO; Gaulden JM; France KA; Zhou Z; Kleinerman ES; Lessnick SL; Denny CT
    Cancer Res; 2007 Jul; 67(14):6675-84. PubMed ID: 17638877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M; Reif S; Hecht K; Pelka-Fleischer R; Kroell T; Pfister K; Schmetzer H
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon gamma enhances the effectiveness of tumor necrosis factor-related apoptosis-inducing ligand receptor agonists in a xenograft model of Ewing's sarcoma.
    Merchant MS; Yang X; Melchionda F; Romero M; Klein R; Thiele CJ; Tsokos M; Kontny HU; Mackall CL
    Cancer Res; 2004 Nov; 64(22):8349-56. PubMed ID: 15548704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A small interfering RNA targeting vascular endothelial growth factor inhibits Ewing's sarcoma growth in a xenograft mouse model.
    Guan H; Zhou Z; Wang H; Jia SF; Liu W; Kleinerman ES
    Clin Cancer Res; 2005 Apr; 11(7):2662-9. PubMed ID: 15814647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical in vivo study of new insulin-like growth factor-I receptor--specific inhibitor in Ewing's sarcoma.
    Manara MC; Landuzzi L; Nanni P; Nicoletti G; Zambelli D; Lollini PL; Nanni C; Hofmann F; García-Echeverría C; Picci P; Scotlandi K
    Clin Cancer Res; 2007 Feb; 13(4):1322-30. PubMed ID: 17317844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.
    Zhou Z; Lafleur EA; Koshkina NV; Worth LL; Lester MS; Kleinerman ES
    Mol Cancer Res; 2005 Dec; 3(12):685-91. PubMed ID: 16380506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).
    Blumenthal RD; Hansen HJ; Goldenberg DM
    Cancer Res; 2005 Oct; 65(19):8809-17. PubMed ID: 16204051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.